Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Eargo Inc (EAR)

Eargo Inc (EAR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 53,358
  • Shares Outstanding, K 20,762
  • Annual Sales, $ 37,250 K
  • Annual Income, $ -157,490 K
  • 60-Month Beta 1.50
  • Price/Sales 1.13
  • Price/Cash Flow N/A
  • Price/Book 1.18
Trade EAR with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -6.87
  • Most Recent Earnings $-0.71 on 11/07/23
  • Latest Earnings Date 03/28/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.56 +0.39%
on 02/15/24
2.87 -10.45%
on 01/30/24
-0.03 (-1.15%)
since 01/12/24
3-Month
2.52 +1.98%
on 12/19/23
2.87 -10.45%
on 01/30/24
+0.01 (+0.39%)
since 11/15/23
52-Week
1.47 +75.43%
on 10/27/23
8.48 -69.69%
on 02/16/23
-5.96 (-69.87%)
since 02/15/23

Most Recent Stories

More News
NationsBenefits and Eargo Announce Partnership to Offer Over-the-Counter Hearing Aids

NationsBenefits®, a leading provider of supplemental benefits, flex cards, and member engagement solutions for health plans, and Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve...

EAR : 2.57 (-4.10%)
Pre-Market Brief: Stocks Mixed After Indices Stage Sharp Reversal

December S&P 500 futures (ESZ22) are trending down -0.20% this morning after three major US benchmark indices made a dramatic recovery, closing sharply higher after an earlier sell-off on Thursday as the...

ESZ22 : 3,871.47s (-0.66%)
IMRA : 6.32 (+15.96%)
EAR : 2.57 (-4.10%)
NVOS : 0.4664 (-8.53%)
RETA : 172.36 (+0.02%)
RLMD : 4.30 (-8.12%)
Eargo, Inc. (EAR) Q2 2022 Earnings Call Transcript

EAR earnings call for the period ending June 30, 2022.

EAR : 2.57 (-4.10%)
Eargo Reports Second Quarter 2022 Financial Results

Financing Update: Strengthened financial position with up to $125 million strategic investment from Patient Square Capital (the “Note Transaction”);...

EAR : 2.57 (-4.10%)
Eargo to Report Second Quarter 2022 Financial Results on August 8, 2022

SAN JOSE, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve hearing health, today...

EAR : 2.57 (-4.10%)
Eargo Closes First Tranche Investment of $100 Million from Patient Square Capital

SAN JOSE, Calif., July 05, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR) (the “Company”), a medical device company on a mission to improve the...

EAR : 2.57 (-4.10%)
Eargo Strengthens Financial Position with up to $125 Million Strategic Investment from Patient Square Capital

Company to Hold Conference Call and Webcast on June 27, 2022 at 8 a.m. Eastern Time...

EAR : 2.57 (-4.10%)
Eargo Strengthens Financial Position with up to $125 Million Strategic Investment from Patient Square Capital

Company to Hold Conference Call and Webcast on June 27, 2022 at 8 a.m. Eastern Time...

EAR : 2.57 (-4.10%)
Eargo to Present at the William Blair 42nd Annual Growth Stock Conference

SAN JOSE, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life for...

EAR : 2.57 (-4.10%)
Eargo Announces Receipt of Nasdaq Non-Compliance Letter

SAN JOSE, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR) (the “Company” or “Eargo”), a medical device company on a mission to improve...

EAR : 2.57 (-4.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Weakening short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Eargo Inc. is a medical device company. Its product and go-to-market approach address challenges of traditional hearing aid adoption. Eargo Inc. is based in SAN JOSE, Calif.

See More

Key Turning Points

3rd Resistance Point 2.70
2nd Resistance Point 2.67
1st Resistance Point 2.62
Last Price 2.57
1st Support Level 2.54
2nd Support Level 2.51
3rd Support Level 2.46

See More

52-Week High 8.48
Fibonacci 61.8% 5.80
Fibonacci 50% 4.97
Fibonacci 38.2% 4.14
Last Price 2.57
52-Week Low 1.47

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar